Stay updated on INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The change is a backend revision update (v3.4.1 added, v3.4.0 removed) with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T13:26:06.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated metadata labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with a revision note of v3.4.0, while removing the previous capitalization variant and the No FEAR Act data label.
    Difference
    0.1%
    Check dated 2026-01-29T06:54:16.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The update timestamp label changed from 'Last Update Posted (Estimated)' to 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-22T04:39:23.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T02:45:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A consolidated Locations section listing all participating states has been added, and the previous per-state location entries were removed. The page shows Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-24T21:38:38.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    New data added: EU CTIS number 2024-512005-87-00 and study completion date 2026-05-01, plus updated last update indicators (2025-11-28, 2025-11). Some older timestamps and the 'Last Update Posted' entry were removed.
    Difference
    0.1%
    Check dated 2025-12-16T15:53:07.000Z thumbnail image

Stay in the know with updates to INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page.